Loading company…
Vantia Therapeutics develops drugs to address unmet medical needs.
Founded in 2008 and based in Southampton, UK, Vantia Therapeutics develops drugs for unmet medical needs. The company raised GBP 7.00 million, most recently in a Series B round co-led by Novo Holdings A/S on March 18, 2016. Its valuation was GBP 27.02 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in